Trial ChiCTR2000029544
Publication Lou Y, Eur J Pharm Sci (2020) (published paper)
Primary outcome on the report: Percentage of subjects with viral negative by Day 14; Time from randomization to clinical improvement, defined as the time from randomization to an improvement of two points (from the status at randomization) on a seven-category ordinal scale or live

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.